SLDB
Price
$5.87
Change
-$0.00 (-0.00%)
Updated
Dec 12 closing price
Capitalization
457.33M
Intraday BUY SELL Signals
TSHA
Price
$5.79
Change
+$0.03 (+0.52%)
Updated
Dec 12 closing price
Capitalization
1.59B
81 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

SLDB vs TSHA

Header iconSLDB vs TSHA Comparison
Open Charts SLDB vs TSHABanner chart's image
Solid Biosciences
Price$5.87
Change-$0.00 (-0.00%)
Volume$648.28K
Capitalization457.33M
Taysha Gene Therapies
Price$5.79
Change+$0.03 (+0.52%)
Volume$2.54M
Capitalization1.59B
SLDB vs TSHA Comparison Chart in %
SLDB
Daily Signal:
Gain/Loss:
TSHA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
SLDB vs. TSHA commentary
Dec 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLDB is a StrongBuy and TSHA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 14, 2025
Stock price -- (SLDB: $5.87 vs. TSHA: $5.76)
Brand notoriety: SLDB and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SLDB: 62% vs. TSHA: 116%
Market capitalization -- SLDB: $457.33M vs. TSHA: $1.59B
SLDB [@Biotechnology] is valued at $457.33M. TSHA’s [@Biotechnology] market capitalization is $1.59B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SLDB’s FA Score shows that 2 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • SLDB’s FA Score: 2 green, 3 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, SLDB is a better buy in the long-term than TSHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLDB’s TA Score shows that 6 TA indicator(s) are bullish while TSHA’s TA Score has 6 bullish TA indicator(s).

  • SLDB’s TA Score: 6 bullish, 4 bearish.
  • TSHA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both SLDB and TSHA are a good buy in the short-term.

Price Growth

SLDB (@Biotechnology) experienced а -0.84% price change this week, while TSHA (@Biotechnology) price change was +13.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Reported Earning Dates

TSHA is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TSHA($1.59B) has a higher market cap than SLDB($457M). TSHA YTD gains are higher at: 232.948 vs. SLDB (46.750). TSHA has higher annual earnings (EBITDA): -98.71M vs. SLDB (-170.67M). TSHA has more cash in the bank: 297M vs. SLDB (236M). SLDB has less debt than TSHA: SLDB (21.9M) vs TSHA (69M). TSHA has higher revenues than SLDB: TSHA (6.31M) vs SLDB (0).
SLDBTSHASLDB / TSHA
Capitalization457M1.59B29%
EBITDA-170.67M-98.71M173%
Gain YTD46.750232.94820%
P/E RatioN/A2.70-
Revenue06.31M-
Total Cash236M297M79%
Total Debt21.9M69M32%
FUNDAMENTALS RATINGS
SLDB: Fundamental Ratings
SLDB
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SLDBTSHA
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
86%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 24 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
SLDB
Daily Signal:
Gain/Loss:
TSHA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSDGX15.570.08
+0.52%
Copeland SMID Cap Dividend Growth A
USWGX35.370.12
+0.34%
Victory Sustainable World A
LIAGX17.35-0.04
-0.23%
Lord Abbett International Growth I
MIPIX17.32-0.04
-0.23%
Matthews Asia Dividend Instl
PIEJX33.52-0.08
-0.24%
Principal Glb Emerging Markets J

SLDB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLDB has been loosely correlated with EDIT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SLDB jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLDB
1D Price
Change %
SLDB100%
-0.17%
EDIT - SLDB
48%
Loosely correlated
-1.54%
SYRE - SLDB
46%
Loosely correlated
-0.87%
DSGN - SLDB
46%
Loosely correlated
-1.91%
BEAM - SLDB
46%
Loosely correlated
+0.40%
RGNX - SLDB
44%
Loosely correlated
-1.61%
More

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with PCVX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then PCVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
+3.60%
PCVX - TSHA
51%
Loosely correlated
+2.53%
NGNE - TSHA
49%
Loosely correlated
+2.41%
RGNX - TSHA
48%
Loosely correlated
-1.61%
ERAS - TSHA
44%
Loosely correlated
+3.68%
SLDB - TSHA
44%
Loosely correlated
-0.17%
More